1. Home
  2. SAR vs NBY Comparison

SAR vs NBY Comparison

Compare SAR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$23.05

Market Cap

369.9M

Sector

Finance

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$5.35

Market Cap

398.2M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
SAR
NBY
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
369.9M
398.2M
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
SAR
NBY
Price
$23.05
$5.35
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$23.75
N/A
AVG Volume (30 Days)
87.9K
638.7K
Earning Date
01-07-2026
11-07-2025
Dividend Yield
12.89%
N/A
EPS Growth
52.15
N/A
EPS
2.38
0.47
Revenue
$130,118,086.00
$10,302,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
$1.28
$32.05
P/E Ratio
$9.77
$114.63
Revenue Growth
N/A
390.34
52 Week Low
$21.10
$0.46
52 Week High
$26.17
$4.44

Technical Indicators

Market Signals
Indicator
SAR
NBY
Relative Strength Index (RSI) 52.50 84.30
Support Level $22.78 $2.92
Resistance Level $23.39 $1.11
Average True Range (ATR) 0.32 0.71
MACD 0.03 0.30
Stochastic Oscillator 60.73 77.05

Price Performance

Historical Comparison
SAR
NBY

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: